CDMO Exothera expands world-first continuous-batch RNA manufacturing solution into North America

Belgium-based CDMO Exothera, a leading provider of nucleic acids and viral vector development and manufacturing services, launched its mRNA Ntensify platform in the North American market, establishing a new site in Andover, Massachusetts.

Developed by Exothera sister company Quantoom Biosciences, Ntensify is the world’s first continuous-batch RNA production platform. It’s designed to fast-track the production of higher quality and more cost-effective RNA therapeutics, delivering significant advantages at both small and large scale.